Rebalancing innovation, affordability, and access for orphan drugs in the European Union
- DOI
- 10.1016/j.lanepe.2026.101778
- Published
- 2026-09
- Container
- The Lancet Regional Health - Europe
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2026.101778,
title = {Rebalancing innovation, affordability, and access for orphan drugs in the European Union},
author = {Hilde Stevens and Georges Siotis and Micael Castanheira and Mathias Dewatripont and Sanae Akodad and Sam Daems and Alain Fischer and Michel Goldman},
year = {2026},
journal = {The Lancet Regional Health - Europe},
doi = {10.1016/j.lanepe.2026.101778},
url = {https://doi.org/10.1016/j.lanepe.2026.101778}
}RIS
TY - JOUR TI - Rebalancing innovation, affordability, and access for orphan drugs in the European Union AU - Hilde Stevens AU - Georges Siotis AU - Micael Castanheira AU - Mathias Dewatripont AU - Sanae Akodad AU - Sam Daems AU - Alain Fischer AU - Michel Goldman PY - 2026 JO - The Lancet Regional Health - Europe DO - 10.1016/j.lanepe.2026.101778 UR - https://doi.org/10.1016/j.lanepe.2026.101778 ER -
APA
Stevens, H., Siotis, G., Castanheira, M., Dewatripont, M., Akodad, S., Daems, S., Fischer, A., & Goldman, M. (2026). Rebalancing innovation, affordability, and access for orphan drugs in the European Union. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2026.101778
Source records
- crossref · retrieved 2026-09-26T13:36:08.713Z